Yunming Mu

Yunming Mu has extensive work experience in the field of biostatistics. They currently hold the position of Head of Biostatistics at REVOLUTION Medicines since April 2021. Prior to that, they worked at AbbVie as the Director of Early Oncology Statistics from August 2019 to April 2021. They also served as the Director of Biostatistics at Ultragenyx Pharmaceutical Inc. from August 2017 to August 2019. Before transitioning into industry roles, Yunming Mu held various positions at Genentech, including Principal Statistical Scientist, Senior Statistical Scientist, and Senior Biostatistician. They also worked as an Assistant Professor at Portland State University and Texas A&M University.

Yunming Mu earned a PhD in Statistics from the University of Illinois Urbana-Champaign in 2005.